glp-1 and autoimmune disease Agonists in GLP-1 Genetics: How Genes Affect
Description
Neuroscience-Informed Dietitian | Behavior Change Specialist Expert in cravings, brain-based eating behavior, and shame-free counseling Session : From Craving to Clarity: GLP-1s Neurological Impact Neuroscience-Informed Dietitian | Behavior Change Specialist Expert in cravings, brain-based eating behavior, and shame-free counseling Accredited Practising Dietitian | Counseling Educator | Behavior Change Researcher | PhD Candidate | Dietitian of the Year 2024 (Australia) Session : Enhancing Medical Referral Practices to Dietetic Services for Clients on GLP-1s Stephanie will share how her framework can lead to effective counseling and coaching, empowering you to get more referrals and optimize your client retention while delivering higher-impact sessions that drive change

GLP-1 Background and history Mimics glucagon-like peptide (GLP-1), a hormone that regulates appetite and food intake Doses administered once weekly or once daily Dosages titrated up over several months for maximum results Are GLP-1s right for you

Key drug-disease associations covered include: 1
In the STEP and SURMOUNT trial programs, participants treated with semaglutide and tirzepatide respectively achieved average weight reductions of 15 to 22% of total body weight, losses that had previously been achievable only through bariatric surgery [8,9]

If you meet the initial GLP-1 requirements and are ready to explore this option, the most important step is connecting with a healthcare provider who can evaluate your individual situation

Injected semaglutide binds to these GLP-1 receptors and reduces appetite for nearly a week, ultimately causing people to eat less and lose weight